GEHC Stock May Gain From Potential FDA Clearance for CleaRecon DL

GE HealthCare Technologies Inc. (GEHC) recently announced the 510(k) submission to the FDA for CleaRecon DL, a deep-learning technology. The company is looking to get FDA clearance for the technology designed to improve the quality of cone-beam computed tomography (CBCT) images by bringing artificial intelligence (AI)-based 3D reconstruction to the interventional suite.GE HealthCare is committed to assisting physicians in utilizing image guidance technologies to their maximum capacity by removing obstacles ...